ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,207, issued on Sept. 9, was assigned to GALECTO BIOTECH AB (Copenhagen, Denmark).
"Galactoside inhibitor of galectins" was invented by Fredrik Zetterberg (Askim, Sweden) and Kristoffer Peterson (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "A D-galactopyranose compound of formula (1) wherein the pyranose ring is Alpha-D-galactopyranose, and these compounds are high affinity galectin-3 inhibitors. Also, pharmaceutical compositions including these compounds. Further, a method for treatment of a disorder relating to the binding of a galectin-3 to a ligand, such as inflammation, in a mammal, such as a human, wherein a therapeutically effe...